, welcome to your FemTech Fund Dashboard!

Portfolia’s 2024 Performance Reports are now available for all funds. COO Tammi Jantzen will present an overview April 3rd on Understanding Performance Reports and K-1s. Register Now to secure your spot.

Live and interactive meetings will be held for Fund Members with Fund management teams from April 20 to May 15. Stay tuned for detailed schedules.

Join the Waitlist

The Portfolia Investor Summit has officially reached capacity. If you’d like to join us, please add your information below. We will be in touch if space becomes available.

Join the Waitlist

As we focus on performance, the Rising America Funds continue to be among our highest performers with Fund I in the top 5% of all venture capital funds of its vintage year. With a strong focus in healthcare and fintech, secure your spot now in Rising America Fund III.

FemTech Fund is currently at 1.02x net TPVI, meaning every $1 invested by the fund is worth $1.02. Portfolia's dedicated healthcare funds operate on a longer development and return cycle due to the nature of the sector. Unlike other areas of venture investing, healthcare companies must navigate rigorous safety and efficacy standards, including FDA regulatory trials and approval processes. While enterprise and technology investments may fail to meet expectations as a natural part of venture risk, setbacks in healthcare can have far-reaching consequences, potentially delaying critical treatments or life-saving innovations. With 8 active companies in FemTech Fund, including Maven and Bone Health, we expect to see significant future distributions from the fund.

Annual Fund Performance Report

2024 FemTech Fund Performance Updates

The 2024 financial statements are as of and for December 31, 2024. Please note all updates provided are confidential and not for distribution. To access the file, please use password: 2024FTReport!

ACCESS THE REPORT

Quarterly Reports

The highlights of Q4 2024 updates as provided by the company. Please note all updates provided are confidential and not for distribution.

To access the file, please use password: Q424FT!

ACCESS THE REPORT

FemTech I Portfolio Highlights

The Companies & Leadership Team

The Portfolia FemTech I Fund is led by a world-class team of highly sophisticated and experienced investors who are leaders in their respective fields, as venture capitalists, angel investors, and innovators. They bring an expert skill-set including sourcing, diligence, deal negotiation, executive recruitment, strategy and governance. Click on photos for full bios.

The Companies

Featured

Future Family helps families more easily afford fertility services like IVF and egg freezing.

Madorra has developed the first effective, non- hormonal treatment and new treatment paradigm for vaginal dryness.

A telehealth network delivering on-demand access to virtual care and services, built specifically for women and families.

A medical device company treating pulmonary arterial hypertension (PAH) by developing ways to enhance both the survival and quality of life of those with PAH.

Leveraging NASA research to develop a wearable medical device that is tackling an epidemic of low bone mass - osteopenia (moderate bone loss) and osteoporosis (severe bone loss).

Sana Health is redefining the way pain is being treated with a non-invasive device helping patients manage chronic pain.‏‏‎ ‎‏‏‎

An emerging women’s health company focused on a revolutionary non-surgical office-based treatment for unexpected bladder leaks, the primary symptom of female Stress Urinary Incontinence (SUI).

Developer of medical testing kits designed to offer diagnostics testing in less time.

Willow develops an in-bra wearable breast pump that is cordless and spill-proof. This also tracks milk output through a mobile app and online portal allowing for mothers to pump anywhere without hassle.

Portfolia Fund Partners

Featured

Dr. Faz Bashi

Board Member, Angel Capital Association; Faculty, Venture Capital Institute. Lead on Future Family.

Claire England

FemTech, Food & AgTech

Kauffman Fellow, Veteran investor in technology, food & beverage, CPG, and healthcare; 20+ years leadership and operations experience

Jennifer Fried

ExplORer Surgical, CEO and Co-Founder

Dr. Christina Jenkins

Healthcare Strategic Advisor and Consultant

Nola Masterson

Biotech business executive and venture capitalist; California Life Sciences Institute, Chair Emeritus. Lead on Future Family.

Dr. Mary Lake Polan

Stanford University School of Medicine, Former Chair of the Department of Obstetrics and Gynecology; Yale University School of Medicine, Professor of Clinical Obstetrics and Gynecology